FDA Declines to Approve Relacorilant for Hypertension Linked to
Hypercortisolism
-
Key takeaways: The FDA issued a complete response letter for relacorilant
to treat hypertension tied to hypercortisolism. The investigational drug
induced ...
10 hours ago

No comments:
Post a Comment